health

Punjab’s drug menace: Why it is hard to curb

Punjab’s drug menace: Why it is hard to curb

Experts cite entrenched smuggling network, alleged police-politician nexus and lucrative trade as major hurdles to eradicating drugs in Punjab

After Parvinder Singh Jhota, an anti-drug crusader, was shot dead on October 13 in Punjab’s Mansa town, protesters demanded resignation of Chief Minister and state Director General of Police, blaming the government in failing to eradicate the drug menace in Mansa on Tuesday, October 27, 2026.

As the 2027 Punjab Assembly election approaches, the drug menace has yet again emerged as the central campaign issue, even as policing experts and academic researchers believe that eliminating the problem, which has persisted for decades, is extremely difficult, given the profitability of the trade, the established network of smugglers and the alleged involvement of police and political patronage behind it.

In the run-up to the election, major political parties, including the Congress, the BJP, the Shiromani Akali Dal (SAD) and the ruling Aam Aadmi Party (AAP), have made drug menace a key campaign plank. While the ruling party has asserted that eradicating drugs is its “biggest priority”, the Opposition has accused the AAP government of failing to curb the drug menace and, instead, patronising the drug trade.

  • drug
  • menace
  • punjab
  • expert
  • smuggling
  • network
  • police
  • politician

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Experts on why your back hurts – and what to do about it
health

Experts on why your back hurts – and what to do about it

Are you one of 600 million people with lower back pain? The World Health Organization (WHO) reports that lower back pain is the leading cause of disability worldwide, with cases projected to rise to more than 800 million by 2050, largely as populations grow and age.

Read →
Rwanda launches Africa’s first trial of long-acting malaria prevention injection
health

Rwanda launches Africa’s first trial of long-acting malaria prevention injection

NAIROBI, Kenya, Nov 6-Rwanda has launched Africa’s first clinical trial of a long-acting injectable drug for malaria prevention, marking a potential shift in how the disease is prevented as drug resistance and climate change threaten progress against the mosquito-borne illness. The Phase 1b trial, launched by Medicines for Malaria Venture (MMV) in partnership with Rwandan health research organisation Rinda Ubuzima, will assess the safety and tolerability of MMV371, an experimental drug designed to provide extended protection against malaria through a single injection.

Read →